https://www.selleckchem.com/pr....oducts/anlotinib-al3
To evaluate the performance of radiomic features extracted from high-resolution computed tomography (HRCT) for the differentiation between cholesteatoma and middle ear inflammation (MEI), and to investigate the impact of post-reconstruction harmonization and data resampling. One hundred patients were included in this retrospective dual-center study 48 with histology-proven cholesteatoma (center A 23; center B 25) and 52 with MEI (A 27; B 25). Radiomic features (co-occurrence and run-length matrix, absolute gradient, autoregress
Like
Comment
Share
